Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • LinkedIn
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Arteriosclerosis, Thrombosis, and Vascular Biology

  • My alerts
  • Sign In
  • Join

  • Facebook
  • LinkedIn
  • Twitter
  • Home
  • About this Journal
    • Editorial Board
    • Meet the Editors
    • ATVB Journal History
    • General Statistics
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • Cover Art Award
    • ATVB Early Career Award
    • ATVB in Focus
    • Recent Brief Reviews of ATVB
    • Lecture Series
    • Collections
    • Recent Highlights of ATVB
    • Commentaries
    • Browse Abstracts
    • Insight into ATVB Authors
  • Resources
    • Instructions for Authors
    • Online Submission/Peer Review Site
    • Council on ATVB
    • Permissions and Rights Q&A
    • AHA Guidelines and Statements
    • Customer Service and Ordering Information
    • Author Reprints
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Basic Sciences

Endothelial Cell Autophagy Maintains Shear Stress–Induced Nitric Oxide Generation via Glycolysis-Dependent Purinergic Signaling to Endothelial Nitric Oxide Synthase

Leena P. Bharath, Jae Min Cho, Seul-Ki Park, Ting Ruan, Youyou Li, Robert Mueller, Tyler Bean, Van Reese, Russel S. Richardson, Jinjin Cai, Ashot Sargsyan, Karla Pires, Pon Velayutham Anandh Babu, Sihem Boudina, Timothy E. Graham, J. David Symons
Download PDF
https://doi.org/10.1161/ATVBAHA.117.309510
Arteriosclerosis, Thrombosis, and Vascular Biology. 2017;37:1646-1656
Originally published July 6, 2017
Leena P. Bharath
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jae Min Cho
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seul-Ki Park
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ting Ruan
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Youyou Li
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Mueller
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tyler Bean
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Van Reese
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Russel S. Richardson
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinjin Cai
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashot Sargsyan
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karla Pires
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pon Velayutham Anandh Babu
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sihem Boudina
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy E. Graham
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. David Symons
From the Department of Nutrition and Integrative Physiology, College of Health (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., R.S.R., K.P., V.A.B., S.B., T.E.G., J.D.S.) and Molecular Medicine Program (J.C., A.S., S.B., T.E.G., J.D.S.), University of Utah, Salt Lake City; Division of Endocrinology, Metabolism, and Diabetes, University of Utah School of Medicine, Salt Lake City (L.P.B., J.M.C., S.-K.P., T.R., Y.L., R.M., T.B., J.C., A.S., K.P., S.B., T.E.G., J.D.S.); and University of Utah Geriatric Research, Education, and Clinical Center, George E. Whalen VA Medical Center, Salt Lake City (V.R., R.S.R.).
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Loading

Visual Overview

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Abstract

Objective—Impaired endothelial cell (EC) autophagy compromises shear stress–induced nitric oxide (NO) generation. We determined the responsible mechanism.

Approach and Results—On autophagy compromise in bovine aortic ECs exposed to shear stress, a decrease in glucose uptake and EC glycolysis attenuated ATP production. We hypothesized that decreased glycolysis-dependent purinergic signaling via P2Y1 (P2Y purinoceptor 1) receptors, secondary to impaired autophagy in ECs, prevents shear-induced phosphorylation of eNOS (endothelial nitric oxide synthase) at its positive regulatory site S1117 (p-eNOSS1177) and NO generation. Maneuvers that restore glucose transport and glycolysis (eg, overexpression of GLUT1 [glucose transporter 1]) or purinergic signaling (eg, addition of exogenous ADP) rescue shear-induced p-eNOSS1177 and NO production in ECs with impaired autophagy. Conversely, inhibiting glucose transport via GLUT1 small interfering RNA, blocking purinergic signaling via ectonucleotidase-mediated ATP/ADP degradation (eg, apyrase), or inhibiting P2Y1 receptors using pharmacological (eg, MRS2179 [2′-deoxy-N6-methyladenosine 3′,5′-bisphosphate tetrasodium salt]) or genetic (eg, P2Y1-receptor small interfering RNA) procedures inhibit shear-induced p-eNOSS1177 and NO generation in ECs with intact autophagy. Supporting a central role for PKCδT505 (protein kinase C delta T505) in relaying the autophagy-dependent purinergic-mediated signal to eNOS, we find that (1) shear stress–induced activating phosphorylation of PKCδT505 is negated by inhibiting autophagy, (2) shear-induced p-eNOSS1177 and NO generation are restored in autophagy-impaired ECs via pharmacological (eg, bryostatin) or genetic (eg, constitutively active PKCδ) activation of PKCδT505, and (3) pharmacological (eg, rottlerin) and genetic (eg, PKCδ small interfering RNA) PKCδ inhibition prevents shear-induced p-eNOSS1177 and NO generation in ECs with intact autophagy. Key nodes of dysregulation in this pathway on autophagy compromise were revealed in human arterial ECs.

Conclusions—Targeted reactivation of purinergic signaling and PKCδ has strategic potential to restore compromised NO generation in pathologies associated with suppressed EC autophagy.

  • autophagy
  • cell physiological phenomena
  • endothelial cells
  • nitric oxide
  • reactive oxygen species

Introduction

Highlights

  • Inhibiting autophagosome formation in bovine aortic endothelial cells (ECs) diminishes shear stress activation of endothelial nitric oxide synthase and subsequent nitric oxide generation while amplifying inflammation and exaggerating oxidant stress.

  • Compromised EC autophagy impairs EC glycolysis, ATP production, and P2Y purinoceptor 1 receptor–mediated signaling to endothelial nitric oxide synthase via protein kinase C delta to ultimately attenuate shear-induced nitric oxide generation.

  • This phenotype can be recapitulated in ECs with intact autophagy and rescued in ECs with genetic repression of autophagy by manipulating nodes in this signaling cascade.

  • Key nodes of dysregulation in this pathway on autophagy compromise were revealed in human arterial ECs after pharmacological suppression of autophagy and in adult mice with temporal deletion of EC autophagy.

  • Targeted reactivation of purinergic signaling and protein kinase C delta has strategic potential to restore compromised nitric oxide generation in pathologies associated with suppressed EC autophagy.

Common among many vascular pathologies is an altered endothelial cell (EC) phenotype (ie, endothelial dysfunction).1,2 A crucial aspect of EC dysfunction is compromised nitric oxide (NO) bioavailability that results from decreased NO synthesis and/or increased NO degradation. Molecular mechanisms responsible for endothelial dysfunction are unclear, and new targets for therapeutic intervention are required.

Autophagy is a highly conserved trafficking process through which intracellular components, including soluble proteins and protein aggregates, carbohydrates, lipids, membranes, cytoskeletal components, and organelles, are delivered to lysosomes. Cargo delivered to lysosomes by autophagy is degraded by lysosomal acid hydrolases, producing metabolites that can be recycled for use in new biosynthetic reactions, or diverted to metabolic pathways that generate ATP. Autophagy, therefore, plays a critical role in maintaining cellular homeostasis.3,4

Intriguing but limited evidence from human subjects suggests that compromised EC autophagy is associated with NO-mediated arterial dysfunction in the context of aging5 and type 2 diabetes mellitus.6 However, concurrent risk factors associated with aging and type 2 diabetes mellitus have potential to impair eNOS (endothelial NO synthase) activity independent from suppressed EC autophagy and cannot be overlooked as contributing to the dysregulated EC phenotype.

Earlier, we determined whether autophagy suppression per se compromises shear stress–evoked activation of eNOS and subsequent NO generation.7 Shear stress increased autophagosome formation and NO generation in ECs. Genetic inhibition of autophagy by small interfering RNA (siRNA)–mediated knockdown of Atg3 (autophagocytosis-associated protein 3) prevented shear-induced phosphorylation of eNOS at its positive regulatory site S1117 (p-eNOSS1177), negated NO generation, amplified reactive oxygen species (ROS) production, and unleashed proinflammatory and adhesive responses, indicating that autophagy is critical for normal EC function. Although recent studies have confirmed our first report that shear stress increases indices of autophagy in ECs8,9 and arteries,8 none have concurrently measured NO generation in the absence and presence of autophagy inhibition, and the mechanism(s) by which compromised autophagy in ECs jeopardizes shear-induced NO generation is unknown. The purpose of the present study was to determine the mechanism by which suppressed EC autophagy compromises shear-induced EC NO production.

Materials and Methods

Materials and Methods are available in the online-only Data Supplement.

Results

Shear Stress Increases Autophagy and Mitochondrial Turnover in ECs

Bovine aortic ECs were exposed to no shear (−shear) or ≈20 dyn/cm2 for 3 hours (+shear). Shear stress increased Atg3 (Figure 1A) and Atg5 (Figure IA in the online-only Data Supplement) protein expression, LC3 (microtubule-associated protein light chain 3)-II accumulation (Figure 1B) and p62 degradation (Figure IB in the online-only Data Supplement), and LC3:GFP (green fluorescent protein) puncta formation (Figure 1C and 1E).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Genetic disruption of Atg3 (autophagocytosis-associated protein 3) impairs shear stress–induced autophagy, mitophagy, and nitric oxide (NO) generation. Relative to static conditions, shear stress increased Atg3 protein expression (A), LC3 (microtubule-associated protein light chain 3) II accumulation (B), LC3-GFP (green fluorescent protein) puncta formation (C and E), colocalization of TOM20 (translocase of outer membrane 20) with LAMP1 (lysosome-associated membrane protein 1; D and F), p-eNOSS1177(G), and NO generation (H–J) in endothelial cells (ECs) transfected with scrambled small interfering RNA (siRNA; bar 1 vs 2) but not in ECs transfected with Atg3 siRNA (bar 3 vs 4) or in ECs after treatment with 3-methyladenine (3-MA; C, bar 5 vs 6). Images shown in (E, F, and J) represent mean data shown in (C, D, and I), respectively. Fluorescence images in (E) and (F) were individually adjusted to maximize clarity. Calibration bar, 50 µm. For A and B, n=30; C and D, n=10; E and F, n=6; G and H, n=30; I and J, n=10. For A, B, and G, each n=1×10 cm petri dish. For C and D, each n=1 well of a 24-well plate. For H, each n=1 well of a 6-well plate. For C, D, E, and F, each n=10 cells per field×10 fields per slide. For I and J, each n=3 wells of a 6-well plate. *P<0.05 vs (−shear; −Atg3 siRNA); #P<0.05 vs (+shear; −Atg3 siRNA). DAF indicates diaminofluorescein; eNOS, endothelial nitric oxide synthase; and EPR, electron paramagnetic resonance spectroscopy.

Autophagy is an important regulator of mitochondrial turnover (ie, mitophagy).10 We observed shear-induced degradation of mitochondrial aconitase and translocase of outer membrane 20 (Figure IC and ID in the online-only Data Supplement), together with colocalization of translocase of outer membrane 20 with lysosome-associated membrane protein 1 (Figure 1D and 1F) and translocase of outer membrane 20 with LC3 (Figure IE and IF in the online-only Data Supplement). These latter findings demonstrate that mitochondrial turnover is elevated in response to shear stress.

Shear-induced LC3-II accumulation was greater, whereas p62 degradation was prevented in the presence versus the absence of bafilomycin A-1 (Figure IG and IH in the online-only Data Supplement), confirming that shear stress increases autophagosome formation rather than decreases autophagosomal degradation by the lysosome.7 All indices of shear-induced EC autophagy and mitophagy we measured were prevented by repressing Atg3 (Figure 1A–1F; Figure IB–IF in the online-only Data Supplement) or Atg5 (Figure IA, II, and IJ in the online-only Data Supplement) protein expression. Using an alternative approach, shear-induced LC3:GFP puncta formation was negated by pharmacological inhibition of autophagy using the class III PI3K (phosphatidylinositol 3-kinase) inhibitor 3-methyladenine (Figure 1C and 1E). These data indicate that shear stress increases EC autophagy and mitophagy and demonstrate that genetic and pharmacological approaches we used to limit autophagy do not alter cell viability (Figure IIA–IIC in the online-only Data Supplement).

Autophagy Suppression Limits Shear Stress–Induced NO Generation in ECs

Shear stress increased p-eNOSS1177 and NO generation in ECs transfected with scrambled but not Atg3 (Figure 1G–1J) or Atg5 siRNA (Figure IIIA and IIIB in the online-only Data Supplement). Impairment of autophagy exacerbated shear-induced ROS production (Figure IVA in the online-only Data Supplement) and unleashed markers of inflammation and adhesion (Figure IVB–IVF in the online-only Data Supplement). These findings confirm that vascular autophagy plays a critical role in maintaining NO bioavailability and regulating oxidant/antioxidant balance and inflammatory/anti-inflammatory balance in ECs.

Shear-Induced Phosphatase, Kinase, and ROS Signaling After Autophagy Suppression

Protein phosphatases and kinases, respectively, remove and add phosphate groups from target proteins,11,12 including eNOS.13–17 Vascular PP2A (protein phosphatase 2A) activity is increased in pathologies associated with suppressed p-eNOSS1177 and compromised endothelial function.16,18–20 We observed no evidence that shear stress altered PP2A activation in the absence or presence of Atg3 siRNA.

To determine whether disrupted kinase signaling to eNOS might compromise NO synthesis secondary to repressed autophagy, we assessed p-AktS473, p-AktT308, p-ERK1/2 (phosphorylated extracellular signal regulated kinase 1/2), p-p38MAPK (phosphorylated p38 mitogen-activated protein kinase), and p-AMPKT172 (phosphorylated 5′ AMP-activated protein kinase) ± Atg3 siRNA ± 180 minutes of shear stress (Figure IVA–IVF in the online-only Data Supplement). Activating phosphorylation was not different in response to shear stress ± autophagy repression, and we concluded that altered signaling from these kinases to eNOS is not responsible for compromised EC NO generation. It was surprising to us that impairment of autophagy per se elevated p-AMPKT172 (Figure VE in the online-only Data Supplement) and downstream targets (not shown), and this was pursued (see below).

Exaggerated ROS production after Atg3 siRNA (Figure IVA in the online-only Data Supplement) has potential to decrease the synthesis of NO or increase the destruction of NO, and this was examined. Regarding NO synthesis, MAP kinases, such as p38-MAPK and ERK (extracellular signal regulated kinase), are phosphorylated/stimulated by nicotinamide adenine dinucleotide phosphate–generated ROS in vessels from mice with type 2 diabetes mellitus, which concurrently exhibit reduced p-eNOSS1177 and impaired vasorelaxation.21 However, shear-induced p-ERK1/2 and p-p38MAPK were not altered by autophagy compromise (Figure VC and VD in the online-only Data Supplement). Furthermore, pharmacological inhibition of mitogen-activated protein kinase using PD98059 (Figure VC and VF in the online-only Data Supplement) and ERK1/2 using FR180204 (not shown) did not restore blunted shear-induced p-eNOSS1177 (Figure VF in the online-only Data Supplement) after autophagy suppression.

Amplified shear-induced ROS production after Atg3 siRNA has potential to precipitate NO destruction, and this was investigated. After its formation, O2•− reacts rapidly with NO to form peroxynitrite (ONOO−).22 ONOO− causes tyrosine nitration. Nitrotyrosine (ie, 3-NT) is an established estimate for ONOO− formation.22 3-NT formation assessed via immunoblot (Figure VIA and VIB in the online-only Data Supplement) or ELISA (not shown) was not greater in ECs exposed to shear stress after autophagy compromise. To strengthen these findings, specific sources of ROS were inhibited in an attempt to restore shear-induced p-eNOSS1177 and NO generation in ECs after autophagy suppression. Mitochondria were targeted first because mitophagy was repressed after Atg3 siRNA (Figure 1D and 1F; Figure IC and ID in the online-only Data Supplement), and it is not unreasonable to hypothesize that accumulation of these organelles might provide a potent source for ROS production. Even though mito-tempo was efficacious with regard to attenuating shear-induced ROS accumulation in ECs with compromised autophagy (Figure VIC in the online-only Data Supplement), a restoration of p-eNOSS1177 and NO generation was not observed (Figure VID and VIE in the online-only Data Supplement). Likewise, while the intracellular ROS scavenger N-acetyl cysteine prevented ROS accumulation in the context of autophagy repression (Figure VIF in the online-only Data Supplement), neither p-eNOSS1177 nor NO generation was preserved in ECs exposed to shear stress (Figure VIG and VIH in the online-only Data Supplement). Neither mito-tempo (Figure VIIA in the online-only Data Supplement) nor N-acetyl cysteine (Figure VIIB in the online-only Data Supplement) altered shear-induced autophagy ± Atg3 siRNA. A similar pattern of results concerning ROS and p-eNOSS1177 was recapitulated with the intracellular O2•− scavenger tiron, the complex IV inhibitor potassium cyanide, and the nicotinamide adenine dinucleotide phosphate oxidase inhibitor N-vanillynonanamide23,24 (not shown). The ability of 2′,7′-dichlorofluorescin diacetate fluorescence to detect ROS and results concerning cell viability ± the various antioxidant treatments are shown in Figure VIIC and VIID in the online-only Data Supplement, respectively.

Autophagy Suppression Compromises Glycolysis in ECs

Elevated p-AMPKT172 in ECs after autophagy compromise (Figure VE in the online-only Data Supplement) suggests an energy stress. ECs derive ATP primarily from glycolysis.25,26 We examined whether autophagy suppression evokes an energetic deficit in ECs. When ECs transfected with scrambled siRNA were exposed to shear stress, they displayed the expected increase in GLUT1 (glucose transporter 1) expression—the main glucose transporter in ECs—3H-deoxyglucose uptake, and cellular ATP production. Relative to control ECs, each response was prevented in ECs transfected with Atg3 (Figure 2A–2C) or Atg5 siRNA (not shown). Because these data suggested that autophagy compromise impairs EC glycolysis, we measured the extracellular acidification rate (ECAR; a surrogate measure of lactic acid production) using the XF24 Seahorse Bioanalyzer.27 Compared with ECs exposed to no shear, shear stress increased ECAR in ECs transfected with scrambled but not Atg3 siRNA, and results were similar under basal and maximal (ie, +carbonyl cyanide-4-[trifluoromethoxy] phenylhydrazone) conditions (Figure VIII in the online-only Data Supplement). These findings motivated us to complete a glycolysis stress test, that is, ECAR was assessed in ECs challenged with shear stress ± autophagy suppression under the following conditions: 0 mmol/L glucose, 5 mmol/L glucose (to stimulate glycolysis, lactate production, and increase ECAR), 1 µmol/L oligomycin (to inhibit mitochondrial ATP production), and 50 mmol/L 2-deoxyglucose (to inhibit glycolysis; Figure 2D). Basal, glucose-stimulated, and oligomycin-stimulated ECAR was suppressed after Atg3 siRNA. As expected, 2-deoxyglucose inhibited ECAR in ECs transfected with scrambled but not Atg3 siRNA. These findings collectively indicate that EC autophagy suppression impairs EC glycolysis.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Genetic disruption of Atg3 (autophagocytosis-associated protein 3) impairs endothelial cell (EC) glycolysis and nitric oxide (NO) generation. Relative to static conditions, shear stress increased GLUT1 (glucose transporter 1) protein expression (A), glucose uptake (B), ATP production (C and G), p-eNOSS1177 (H), and NO generation (I) in ECs transfected with scrambled small interfering RNA (siRNA; bar 1 vs 2) but not Atg3 siRNA (bar 3 vs 4). For A–C, n=8–12. For A, each n=1×10 cm petri dish. For B and C, each n=1 well of a 6-well plate. For A–C, *P<0.05 vs (−shear; −Atg3 siRNA); #P<0.05 vs (+shear; −Atg3 siRNA). Extracellular acidification rate (ECAR) was assessed in ECs exposed to shear stress ± Atg3 siRNA (D). Relative to basal conditions, ECs transfected with scrambled siRNA displayed increased ECAR in response to 5 mmol/L glucose (bar 1 vs 3) and 1 µmol/L oligomycin (oligo; bar 1 vs 5), but these responses were not observed in ECs after Atg3 siRNA (bar 2 vs 4; bar 2 vs 6, respectively). Relative to basal conditions, ECAR decreased on treatment with 50 mmol/L 2-DG (2-deoxy D glucose) in ECs transfected with scrambled (bar 1 vs 7) but not Atg3 siRNA (bar 2 vs 8). For D, n=3, each n=1 seahorse plate. For D, *P<0.05 vs basal condition (+shear; −Atg3 siRNA ie, bar 1); #P<0.05 vs same condition (+shear; −Atg3 siRNA). Relative to static conditions, shear stress increased ATP (E) and p-eNOSS1177 (F) in ECs transfected with scrambled siRNA (bar 1 vs 2) but not GLUT1 siRNA (bar 3 vs 4). For E, n=12, each n=1 well of a 6-well plate. For F, n=6, each n=1×10 cm petri dish. For E and F, *P<0.05 vs (−shear; −Atg3 siRNA); #P<0.05 vs (+shear; −Atg3 siRNA). After cotransfection with a plasmid vector to increase GLUT1 expression in ECs (G–I), the suppression of shear-induced ATP (G), p-eNOSS1177 (H), and NO generation (I) after autophagy repression (bar 2 vs 4) was not observed (bar 6 vs 8). For G–I, n=4, each n=1×10 cm petri dish). For G–I, *P<0.05 vs (−shear; −Atg3 siRNA); #P<0.05 vs (+shear; −Atg3 siRNA). DAF indicates diaminofluorescein; and eNOS, endothelial nitric oxide synthase.

To determine whether impaired EC glycolysis after autophagy compromise might negate shear-induced NO generation, we first used a loss-of-function approach. ECs with ≈65% knockdown of GLUT1 via siRNA (Figure IXA in the online-only Data Supplement) exhibited depressed shear-induced ATP production (Figure 2E) and were refractory to shear-induced p-eNOSS1177 (Figure 2F). Second, we used a gain-of-function approach. When ECs with suppressed autophagy were transfected with a plasmid vector that increased GLUT1 expression by ≈50% (Figure IXB in the online-only Data Supplement), shear-induced ATP production, p-eNOSS1177, and NO generation (Figure 2G–2I) were restored. Cell viability and indices of autophagy, respectively, were not altered by GLUT1 siRNA (Figure IXC an IXD in the online-only Data Supplement) or GLUT1 overexpression (Figure IXE and IXF in the online-only Data Supplement).

Autophagy Suppression Impairs Purinergic-Mediated Activation of eNOS

It is established that ECs produce ATP in response to shear stress and that extracellular ATP/ADP signals via purinergic receptors to activate p-eNOSS1177 and NO generation.28,29 As would be predicted from cellular ATP results shown in Figure 2C, 2E, and 2G, shear-induced extracellular ATP accumulation was robust in ECs transfected with scrambled but not Atg3 siRNA (Figure 3A), prevented in control ECs transfected with GLUT1 siRNA (Figure 3B), and restored by GLUT1 overexpression in ECs with compromised autophagy (Figure 3C).

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Genetic disruption of Atg3 (autophagocytosis-associated protein 3) limits purinergic-mediated activation of eNOS (endothelial nitric oxide synthase). Relative to static conditions, shear stress increased extracellular ATP accumulation (A–C), p-eNOSS1177 (D–G), and nitric oxide (NO) generation (H) in endothelial cells (ECs) transfected with scrambled small interfering RNA (siRNA; bar 1 vs 2) but not Atg3 siRNA (A, C, D, and E; bar 3 vs 4) or GLUT1 (glucose transporter 1) siRNA (B; bar 3 vs 4). After cotransfection with a plasmid vector to increase GLUT1 expression in ECs (C), the suppression of shear-induced ATP after autophagy compromise (bar 2 vs 4) was normalized (bar 6 vs 8). The ectonucleotidase apyrase (D), the pharmacological P2Y1-R (P2Y purinoceptor 1 receptor) blocker MRS2179 (2′-deoxy-N6-methyladenosine 3′,5′-bisphosphate tetrasodium salt; E), and genetic disruption of P2Y1-R via siRNA (F) prevented shear-induced p-eNOSS1177 in ECs with intact Atg3 protein (bar 5 vs 6). Conversely exogenous 2-methylthio ADP restored shear-induced p-eNOS S1177 (G) and NO generation (H) in ECs with suppressed autophagy (bar 7 vs 8). For A–C and H, n=6, each n=1 well of a 6-well plate. For D–G, n=5, each n=1×10 cm petri dish. *P<0.05 vs (−shear; −Atg3 siRNA); #P<0.05 vs (+shear; −Atg3 siRNA).

If limited extracellular ATP is responsible for suppressed shear-induced NO generation in ECs with compromised autophagy, then promoting extracellular ATP breakdown in ECs with intact autophagy or blocking the dominant purinergic receptor in ECs with intact autophagy30 should independently recapitulate the phenotype displayed by ECs with impaired autophagy. Supporting this notion, shear stress did not increase p-eNOSS1177 when ECs transfected with scrambled siRNA were treated concurrently with apyrase, an ectonucleotidase that hydrolyzes ATP to AMP and inorganic phosphate (Figure 3D), or MRS2179 (2′-deoxy-N6-methyladenosine 3′,5′-bisphosphate tetrasodium salt), a P2Y1 (P2Y purinoceptor 1) receptor blocker (Figure 3E).31 A genetic approach was used to strengthen these findings. When the P2Y1 receptor was silenced by ≈45% via siRNA in ECs with intact autophagy (Figure XA in the online-only Data Supplement), shear stress was incapable of activating eNOS when compared with results from ECs transfected with scrambled siRNA (Figure 3F). Importantly, P2Y1 receptor expression was not different ± shear stress ± Atg3 siRNA (Figure XA in the online-only Data Supplement), and neither apyrase nor P2Y1-receptor siRNA altered LC3-II:GAPDH or cell viability (Figure XB–XD in the online-only Data Supplement).

To validate that limited extracellular ATP contributes importantly to preventing shear-induced NO generation in ECs with compromised autophagy, we provided exogenous ADP to the cellular milieu in an attempt to restore NO production. ADP rescued shear-induced p-eNOSS1177 (Figure 3G) and NO generation (Figure 3H) in ECs with suppressed autophagy, and neither LC3-II:GAPDH (Figure XE in the online-only Data Supplement) nor cell viability (Figure XD in the online-only Data Supplement) was altered by this treatment.

Autophagy Suppression Impairs Purinergic-Mediated Activation of eNOS via PKCδT505

To this point, our data indicate that when autophagy is suppressed in ECs, a glycolytic defect limits shear-induced ATP production to an extent that purinergic-mediated activation of eNOS is compromised. We sought to identify the link between P2Y1 activation and eNOS phosphorylation. An exploration of the literature revealed that extracellular nucleotide-mediated activation of p-eNOSS1177 in human umbilical vein ECs exposed to shear stress occurs via p-PKCδT505 (phosphorylated protein kinase C delta T505).30 Because we did not assess this kinase originally, historical cellular homogenates treated ± shear ± Atg3 siRNA were retrieved, re-examined, and results indicated that shear-induced p-PKCδT505 was prevented in ECs with suppressed autophagy (Figure 4A). Confirming the importance of this kinase in the context of the current experimental conditions, eNOS activation was refractory to shear stress in ECs transfected with PKCδ versus scrambled siRNA (Figure 4B; producing ≈40% reduction in PKCδ gene expression, Figure XIA in the online-only Data Supplement) and in ECs with intact autophagy treated with the PKCδ inhibitor rottlerin (not shown).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Defective purinergic-mediated p-PKCδT505 (phosphorylated protein kinase C delta T505) activation of eNOS (endothelial nitric oxide synthase) after autophagy compromise is normalized by genetic and pharmacological approaches. Relative to static conditions, shear stress increased p-PKCδT505 (A, E, F, and G) and p-eNOSS1177 (C, D, and H) in endothelial cells (ECs) transfected with scrambled small interfering RNA (siRNA; bar 1 vs 2) but not Atg3 (autophagocytosis-associated protein 3) siRNA (bar 3 vs 4). Relative to static conditions, shear stress increased p-eNOSS1177 in ECs transfected with scrambled but not PKCδ siRNA (B; bar 2 vs 4). Suppressed shear-induced p-eNOS S1177 after Atg3 siRNA was restored in ECs cotransfected with constitutively active (CA) PKCδ (bar 7 vs 8; C) but not dominant-negative (DN) PKCδ (D). Suppressed shear-induced p-PKCδT505 after Atg3 siRNA (A, E, F, and G) could be recapitulated in ECs with intact Atg3 protein that were transfected with P2Y1-R (P2Y purinoceptor 1 receptor) siRNA (bar 5 vs 6; E) or restored in ECs with autophagy compromise by ADP (bar 7 vs 8; F). Suppressed shear-induced p-PKCδT505, p-eNOS S1177, and NO generation in ECs transfected with Atg3 siRNA was restored by the PKCδ agonist bryostatin-1 (bry; bar 4 vs 8, G, H, and I). For A–H, n=5, each n=1×10 cm petri dish. For I, n=6, each n=3 wells of a 6-well plate. *P<0.05 vs (−shear; −Atg3 siRNA); #P<0.05 vs (+shear; −Atg3 siRNA).

Using a gain-of-function approach, when ECs with suppressed autophagy were transfected with constitutively active PKCδ and subsequently challenged with shear stress, p-eNOSS1177 (Figure 4C) and NO generation (Figure XIB and XIC in the online-only Data Supplement) were restored, and indices of autophagy (Figure XID in the online-only Data Supplement) were not altered. Consistent with these findings, when ECs with suppressed autophagy were transfected with dominant-negative PKCδ and subsequently challenged with shear stress, p-eNOSS1177 was not restored (Figure 4D), and indices of autophagy (Figure XIE in the online-only Data Supplement) were unaltered. Protein expression was ≈65% greater or ≈50% greater in ECs transfected with constitutively active or dominant-negative PKCδ, respectively (Figure XIF and XIG in the online-only Data Supplement). Representative EPR (electron paramagnetic resonance spectroscopy) traces and cell death for all treatments are shown in Figure XIIA–XIIC in the online-only Data Supplement.

Next, we confirmed that p-PKCδT505 is a downstream target of purinergic-mediated signaling in our system. Specifically, phosphorylation of this kinase was refractory to shear stress in ECs with intact autophagy after transfection with P2Y1-receptor versus scrambled siRNA (Figure 4E). Substantiating these findings, shear stress evoked robust p-PKCδT505 (and p-eNOSS1177 and NO generation; Figure 3G and 3H) in ECs with repressed autophagy that were treated concurrently with exogenous ADP (Figure 4F).

Bryostatin-1 is a small molecule that binds with and directly activates PKCδ.32–34 To determine whether pharmacological activation might preserve NO production in the context of suppressed autophagy, ECs ± Atg3 siRNA were treated ± shear stress ± bryostatin-1. Defective shear-induced PKCδT505, p-eNOSS1177, and NO generation after autophagy compromise were restored by concurrent treatment with bryostatin-1 (Figure 4G–4I; Figure XIIIA and XIIIB in the online-only Data Supplement). Taken together, our findings indicate that impaired EC autophagy represses glycolysis to an extent that extracellular ATP accumulation is limited, and purinergic signaling via the P2Y1-R and PKCδ to eNOS is blunted.

Translation to Human ECs and Intact Mice

We determined whether major findings observed in bovine aortic endothelial cells (BAECs) might be observed in human cells. Human arterial ECs were treated ± 20 dyn/cm2 for 3 hours ± 5 mmol/L 3-methyladenine. Shear stress increased Atg3:GAPDH, LC3-II:GAPDH, p62 degradation, GLUT1:GAPDH, p-PKCδT505: PKC, p-eNOSS1177: eNOS, and NO generation in the absence but not the presence of autophagy inhibition (Figure 5A–5H). The 3-methyladenine did not alter cell viability (Figure XIVA–XIVC in the online-only Data Supplement). These data are congruent with results from BAECs and demonstrate strong proof of concept for translational relevance.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Pharmacological inhibition of autophagy impairs shear stress–induced nitric oxide (NO) generation in human arterial endothelial cells. Relative to static conditions, shear stress increased Atg3 (autophagocytosis-associated protein 3; A), LC3 (microtubule-associated protein light chain 3) II (B), GLUT1 (glucose transporter 1; D), p-PKCδT505 (phosphorylated protein kinase C delta T505; E) and p-eNOSS1177 (phosphorylated endothelial NO synthase at its positive regulatory site S1117; F) protein expression, NO generation (G), and p62 degradation (C; bar 1 vs 2). All responses were prevented by concurrent treatment with 3-methyladenine (3-MA; bar 3 vs 4). Images shown in the merge portion of H represent mean data shown in G. Calibration bar, 100 µm. For A–F, n=3, each n=2 wells of a 6-well plate. For G and H, n=2, each n=1 well of a 4-well chamber slide. *P<0.05 vs (−shear; −3-MA); #P<0.05 vs (+shear; −3-MA). DAF (diaminofluorescein)-FM indicates 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate; and DAPI, 4′,6-diamidino-2-phenylindole.

Next, we examined whether major findings from ECs studied in vitro could be recapitulated in mice with compromised EC autophagy (Figure 6A–6D). Arterial ECs obtained from mice with tamoxifen-inducible deletion of Atg3 specifically in ECs (iecAtg3KO mice) exhibit the anticipated reduction in Atg3 protein expression and LC3-II:GAPDH, concurrent with suppressed GLUT1:GAPDH and p-eNOSS1177:eNOS, versus results obtained from wild-type controls (Figure 6E–6H). Thus, several key nodes of dysregulation observed in BAECs and human arterial ECs studied in vitro after genetic and pharmacological repression of autophagy are recapitulated in vivo in mice with inducible disruption of EC autophagy. Studies are ongoing to determine the physiological and pathophysiological relevances of these findings.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

iecAtg3KO mice exhibit impaired endothelial cell autophagy, GLUT1 (glucose transporter 1) protein expression, and p-eNOS (phosphorylated endothelial nitric oxide synthase) protein expression vs wild-type (WT) mice. To assess mRNA, endothelial cells (ECs) and media+adventitia were isolated from iliac arteries of 5-mo-old iecAtg3KO and WT mice treated 30 d earlier with tamoxifen. Purity of the EC and media+adventitia fraction was confirmed by PECAM (platelet endothelial cell adhesion molecule-1; A) and α-SMA (smooth muscle actin; B) staining, respectively. Atg3 (autophagocytosis-associated protein 3)/18S mRNA was similar in the media+adventitia component of both groups (C) but was lower in the EC fraction of iecAtg3KO vs WT mice (D). For A–D, n=4 mice per group. *P<0.05 vs media+adventitia (A); vs EC (B); vs WT (D). EC protein was assessed in a different cohort of 5-mo-old mice treated 30 d earlier with tamoxifen. Atg3:GAPDH (E), LC3 (microtubule-associated protein light chain 3) II:GAPDH (F), GLUT1:GAPDH (G), and p-eNOS:eNOS (H) was lower in ECs from iecAtg3KO vs WT mice. For E–H, n=3, each n=ECs obtained from 4 entire aortae. *P<0.05 vs WT. KO indicates knockout.

Discussion

An understanding of the role that autophagy plays in maintaining cytoplasmic homeostasis in the context of health and disease is evolving. Evidence exists that autophagy can exert protective or adverse effects, and the respective response seems to be dynamic, context specific, and cell autonomous. Compared with other tissues, relatively little is known on vascular autophagy in general, and EC autophagy in particular,35–37 but insight on the clinical relevance of EC autophagy is emerging. For example, the absence of endothelial autophagy markedly increased vascular lipid accumulation to an extent that elevated atherosclerotic burden in apolipoprotein E–deficient mice.38

Our goal was to elucidate the molecular mechanisms by which repressed EC autophagy compromises EC NO generation. Rationale for investigating this issue is strong. For example, primary arterial ECs from 61- to 71-year-old (ie, old) humans and aortae from 27- to 28-month-old mice display markers of impaired autophagy and indices of lower NO bioavailability versus the appropriate controls.5 Likewise, peripheral venous ECs obtained from diabetic patients exhibit depressed autophagy and blunted insulin-stimulated p-eNOSS1177.6 Although these interesting studies provide proof of concept that impaired EC autophagy might precipitate compromised EC NO generation, the contribution from concurrent risk factors associated with aging and type 2 diabetes mellitus, with potential to impair eNOS activity independent from suppressed EC autophagy in primary ECs, cannot be overlooked.

Earlier, we reported that after transfection with Atg3 siRNA, ECs were refractory to shear-induced p-eNOSS1177 and NO generation, ROS accumulation was amplified, and inflammatory cytokine production was unmasked.7 These findings were substantiated in the present study, extended to include autophagy suppression via Atg5 siRNA and class III PI3K inhibition using 3-methyladenine (Figure 1; Figures I and III in the online-only Data Supplement), and solid evidence is provided that key findings can be translated to human arterial ECs (Figure 5) and intact mice (Figure 6). In this study, we provide evidence for a unique mechanism by which compromised autophagy impairs shear-induced NO generation.

Our first novel finding is that autophagy suppression impairs EC glycolysis. An initial exploration of candidate pathways that might be responsible for impaired NO synthesis and augmented NO destruction in ECs exposed to shear stress after Atg3 siRNA revealed that neither altered kinase signaling to eNOS, ROS-mediated eNOS enzyme disruption, nor ROS-mediated conversion of NO to peroxynitrite was accountable. ECs derive ATP primarily from glycolysis, and when the resulting metabolic end-product lactate is exported from the cell, the pH of the extracellular milieu is lowered.25,26 By quantifying the ECAR in ECs under basal conditions, and in response to glucose stimulation, ATP synthase inhibition, and glycolysis inhibition, our suspicion of impaired EC glycolysis after autophagy suppression was supported (Figure 2). Consistent with this, shear-induced expression of GLUT1, together with increased glucose uptake, cellular ATP production, and extracellular ATP accumulation, was prevented in ECs after Atg3 siRNA. Importantly, shear-induced NO generation in ECs after autophagy suppression could be rescued by GLUT1 overexpression, and congruent with these observations, shear-induced NO production was prevented in control ECs after GLUT1 siRNA. Taken together, we think these data are the first to indicate that autophagy suppression impairs EC glycolysis.

Our second original finding is that autophagy repression in ECs precludes purinergic-mediated eNOS phosphorylation and NO generation. Extracellular nucleotides have important biological roles as signaling molecules that regulate cellular functions under physiological and pathophysiological conditions.29 eNOS is regulated at multiple levels,39–42 including via nucleotide activation of purinergic receptors.29,30,43,44 Shear stress stimulates the release of ATP in ECs,30,43,45,46 and its hydrolysis product ADP is an important ligand of purinergic receptor–mediated eNOS phosphorylation and NO generation.30 Of the P2Y (G-protein–coupled receptors) and P2X (calcium channels) receptors located on ECs, the importance of P2Y receptor subtype 1 (P2Y1-receptor)–mediated eNOS activation and NO generation has been demonstrated in human umbilical vein ECs,30 bovine aortic ECs,43,44 and cerebromicrovascular ECs.47 Because shear stress failed to elevate cellular and extracellular ATP levels in ECs with suppressed autophagy, we thought it reasonable to test whether purinergic signaling to eNOS was compromised under these conditions. Pharmacological and genetic interference of the P2Y1 receptor in ECs with intact autophagy phenocopied results from ECs with compromised autophagy concerning shear-induced eNOS activation and NO generation, demonstrating the importance of purinergic signaling in general and this receptor subtype in particular. Consistent with these results, exogenous ADP restored shear-induced p-eNOSS1177 and NO generation in ECs with suppressed autophagy (Figure 3). These findings are the first to demonstrate that shear-induced purinergic-mediated activation of eNOS and resultant NO generation are impaired in ECs with suppressed autophagy.

The third important finding presented here is that PKCδ links purinergic-mediated signaling via the P2Y1 receptor to eNOS activation and NO generation. The PKC family of serine–threonine kinases includes conventional, novel, and atypical isoforms.48 As the obtained data directed our focus toward purinergic signaling, we became aware of evidence from human umbilical vein ECs that shear stress increases extracellular nucleotide-mediated activation of p-eNOSS1177 via phosphorylation of the novel PKC isoform δ at threonine 505 (ie, p-PKCδT505).30 We observed that shear stress increases p-PKCδT505 in ECs transfected with scrambled but not Atg3 siRNA and confirmed that p-PKCδT505 is a downstream target of P2Y1-R–mediated signaling. Using a loss-of-function approach, eNOS activation was refractory to shear stress in ECs transfected with PKCδ versus scrambled siRNA and in ECs with intact autophagy treated with the PKCδ inhibitor rottlerin. Gain-of-function procedures substantiated these findings. Specifically, when ECs with suppressed autophagy were transfected with CA PKCδ or treated with a small molecule activator of PKC (ie, bryostatin-1), p-eNOSS1177 and NO generation were restored in response to shear stress (Figure 4). The bryostatins are a family of 20 macrolide natural products isolated from the marine bryozoan Bugula neritina.34 The biologically active constituent bryostatin-1 binds to the regulatory C1 domain of the PKC isoforms,49 and clinical trials have investigated the therapeutic use of bryostatin-1 in the context of neurodegenerative diseases.33,50 Here, we provide evidence that genetic and pharmacological approaches to activate PKC can restore shear stress–mediated eNOS phosphorylation and NO generation in the context of impaired EC autophagy.

EC metabolism is an emerging but understudied therapeutic target. Metabolic abnormalities in ECs have potential to dysregulate vascular function in the context of numerous vascular pathologies. Initiating events that disrupt EC metabolism to an extent that precipitates EC dysfunction in the context of aging51 and diabetes mellitus52 are unclear. Here, we present solid evidence that impaired autophagy suppresses EC glycolysis, resulting in deficient ATP synthesis and release and defective purinergic signaling to eNOS via PKCδ. Many nodes of dysregulation in this pathway were revealed in human arterial ECs exposed to shear stress after pharmacological impairment of autophagy (Figure 5) and several are recapitulated in adult mice with inducible disruption of autophagy specifically in ECs (Figure 6). Current studies are investigating the functional role of EC autophagy in pre-clinical models of aging and diabetes mellitus.

Acknowledgments

Q.J. Zhang, E. Dale Abel, and B.K. Kishore are thanked for their scientific input throughout this study. Diana Lim is thanked for preparing the figures.

Sources of Funding

J.D. Symons was supported by the American Heart Association (AHA: 16GRNT31050004), National Institutes of Health (NIH: RO3AGO52848; 2R15HL091493), American Diabetes Association (ADA: 1-12-BS-208, ADA 7-08-RA-164), and Seed Grants from the University of Utah (UU) Office of the Vice-President for Research, the UU College of Health, the UU Center on Aging, the UU Diabetes and Metabolism Center, and the Diabetes Research Center at Washington University at Saint Louis, grant no. 5 P30 DK020579. S. Boudina was supported by NIH 1R01DK098646-01A1 and an AHA Scientist Development Grant. K. Pires was supported by a post-doctoral fellowship from the AHA, Western States Affiliate. R.S. Richardson was supported by NIH P01 HL-091830, VA RR&D Merit Grants E6910-R and E1697-R, and VA RR&D SPiRE Grant R1433-P. Student support was provided by the American Physiological Society (APS) Undergraduate Summer Research Program, the APS Undergraduate Research Excellence Fellowship Program, the AHA, Western States Affiliate, Undergraduate Student Summer Research Program, and the UU Undergraduate Research Opportunities Program.

Disclosures

None.

Footnotes

  • The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/doi:10.1161/ATVBAHA.117.309510/-/DC1.

  • Nonstandard Abbreviations and Acronyms
    Atg3
    autophagocytosis-associated protein 3
    EC
    endothelial cell
    ECAR
    extracellular acidification rate
    eNOS
    endothelial nitric oxide synthase
    LC3
    microtubule-associated protein light chain 3
    NO
    nitric oxide
    P2Y1
    P2Y purinoceptor 1
    PKCδ
    protein kinase C delta
    ROS
    reactive oxygen species
    siRNA
    small interfering RNA

  • Received December 2, 2016.
  • Accepted June 19, 2017.
  • © 2017 American Heart Association, Inc.

References

  1. 1.↵
    1. Zhang Y,
    2. Janssens SP,
    3. Wingler K,
    4. Schmidt HH,
    5. Moens AL
    . Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy. Am J Physiol Heart Circ Physiol. 2011;301:H634–H646. doi: 10.1152/ajpheart.01315.2010.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Triggle CR,
    2. Hollenberg M,
    3. Anderson TJ,
    4. Ding H,
    5. Jiang Y,
    6. Ceroni L,
    7. Wiehler WB,
    8. Ng ES,
    9. Ellis A,
    10. Andrews K,
    11. McGuire JJ,
    12. Pannirselvam M
    . The endothelium in health and disease–a target for therapeutic intervention. J Smooth Muscle Res. 2003;39:249–267.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Kuma A,
    2. Mizushima N
    . Physiological role of autophagy as an intracellular recycling system: with an emphasis on nutrient metabolism. Semin Cell Dev Biol. 2010;21:683–690. doi: 10.1016/j.semcdb.2010.03.002.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Mizushima N
    . Physiological functions of autophagy. Curr Top Microbiol Immunol. 2009;335:71–84. doi: 10.1007/978-3-642-00302-8_3.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. LaRocca TJ,
    2. Henson GD,
    3. Thorburn A,
    4. Sindler AL,
    5. Pierce GL,
    6. Seals DR
    . Translational evidence that impaired autophagy contributes to arterial ageing. J Physiol. 2012;590:3305–3316. doi: 10.1113/jphysiol.2012.229690.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Fetterman JL,
    2. Holbrook M,
    3. Flint N,
    4. Feng B,
    5. Bretón-Romero R,
    6. Linder EA,
    7. Berk BD,
    8. Duess MA,
    9. Farb MG,
    10. Gokce N,
    11. Shirihai OS,
    12. Hamburg NM,
    13. Vita JA
    . Restoration of autophagy in endothelial cells from patients with diabetes mellitus improves nitric oxide signaling. Atherosclerosis. 2016;247:207–217. doi: 10.1016/j.atherosclerosis.2016.01.043.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Bharath LP,
    2. Mueller R,
    3. Li Y,
    4. Ruan T,
    5. Kunz D,
    6. Goodrich R,
    7. Mills T,
    8. Deeter L,
    9. Sargsyan A,
    10. Anandh Babu PV,
    11. Graham TE,
    12. Symons JD
    . Impairment of autophagy in endothelial cells prevents shear-stress-induced increases in nitric oxide bioavailability. Can J Physiol Pharmacol. 2014;92:605–612. doi: 10.1139/cjpp-2014-0017.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Guo F,
    2. Li X,
    3. Peng J,
    4. Tang Y,
    5. Yang Q,
    6. Liu L,
    7. Wang Z,
    8. Jiang Z,
    9. Xiao M,
    10. Ni C,
    11. Chen R,
    12. Wei D,
    13. Wang GX
    . Autophagy regulates vascular endothelial cell eNOS and ET-1 expression induced by laminar shear stress in an ex vivo perfused system. Ann Biomed Eng. 2014;42:1978–1988. doi: 10.1007/s10439-014-1033-5.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Liu J,
    2. Bi X,
    3. Chen T,
    4. Zhang Q,
    5. Wang SX,
    6. Chiu JJ,
    7. Liu GS,
    8. Zhang Y,
    9. Bu P,
    10. Jiang F
    . Shear stress regulates endothelial cell autophagy via redox regulation and Sirt1 expression. Cell Death Dis. 2015;6:e1827. doi: 10.1038/cddis.2015.193.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Kubli DA,
    2. Gustafsson ÅB
    . Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res. 2012;111:1208–1221. doi: 10.1161/CIRCRESAHA.112.265819.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Wei Q,
    2. Xia Y
    . Proteasome inhibition down-regulates endothelial nitric-oxide synthase phosphorylation and function. J Biol Chem. 2006;281:21652–21659. doi: 10.1074/jbc.M602105200.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Shi Y
    . Serine/threonine phosphatases: mechanism through structure. Cell. 2009;139:468–484. doi: 10.1016/j.cell.2009.10.006.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Park SY,
    2. Ives SJ,
    3. Gifford JR,
    4. Andtbacka RH,
    5. Hyngstrom JR,
    6. Reese V,
    7. Layec G,
    8. Bharath LP,
    9. Symons JD,
    10. Richardson RS
    . Impact of age on the vasodilatory function of human skeletal muscle feed arteries. Am J Physiol Heart Circ Physiol. 2016;310:H217–H225. doi: 10.1152/ajpheart.00716.2015.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Zhang QJ,
    2. McMillin SL,
    3. Tanner JM,
    4. Palionyte M,
    5. Abel ED,
    6. Symons JD
    . Endothelial nitric oxide synthase phosphorylation in treadmill-running mice: role of vascular signalling kinases. J Physiol. 2009;587:3911–3920.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Symons JD,
    2. McMillin SL,
    3. Riehle C,
    4. Tanner J,
    5. Palionyte M,
    6. Hillas E,
    7. Jones D,
    8. Cooksey RC,
    9. Birnbaum MJ,
    10. McClain DA,
    11. Zhang QJ,
    12. Gale D,
    13. Wilson LJ,
    14. Abel ED
    . Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure. Circ Res. 2009;104:1085–1094. doi: 10.1161/CIRCRESAHA.108.189316.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Zhang QJ,
    2. Holland WL,
    3. Wilson L,
    4. et al
    . Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes. 2012;61:1848–1859. doi: 10.2337/db11-1399.
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Bharath LP,
    2. Ruan T,
    3. Li Y,
    4. et al
    . Ceramide-initiated protein phosphatase 2A activation contributes to arterial dysfunction in vivo. Diabetes. 2015;64:3914–3926. doi: 10.2337/db15-0244.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Wu Y,
    2. Song P,
    3. Xu J,
    4. Zhang M,
    5. Zou MH
    . Activation of protein phosphatase 2A by palmitate inhibits AMP-activated protein kinase. J Biol Chem. 2007;282:9777–9788. doi: 10.1074/jbc.M608310200.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Smith AR,
    2. Visioli F,
    3. Frei B,
    4. Hagen TM
    . Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A. Aging Cell. 2006;5:391–400. doi: 10.1111/j.1474-9726.2006.00232.x.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Du Y,
    2. Kowluru A,
    3. Kern TS
    . PP2A contributes to endothelial death in high glucose: inhibition by benfotiamine. Am J Physiol Regul Integr Comp Physiol. 2010;299:R1610–R1617. doi: 10.1152/ajpregu.00676.2009.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Kassan M,
    2. Choi SK,
    3. Galán M,
    4. Lee YH,
    5. Trebak M,
    6. Matrougui K
    . Enhanced p22phox expression impairs vascular function through p38 and ERK1/2 MAP kinase-dependent mechanisms in type 2 diabetic mice. Am J Physiol Heart Circ Physiol. 2014;306:H972–H980. doi: 10.1152/ajpheart.00872.2013.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Pacher P,
    2. Beckman JS,
    3. Liaudet L
    . Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315–424. doi: 10.1152/physrev.00029.2006.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Brar SS,
    2. Kennedy TP,
    3. Whorton AR,
    4. Sturrock AB,
    5. Huecksteadt TP,
    6. Ghio AJ,
    7. Hoidal JR
    . Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells. Am J Physiol Cell Physiol. 2001;280:C659–C676.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Berridge MV,
    2. Tan AS
    . Cell-surface NAD(P)H-oxidase: relationship to trans-plasma membrane NADH-oxidoreductase and a potential source of circulating NADH-oxidase. Antioxid Redox Signal. 2000;2:277–288. doi: 10.1089/ars.2000.2.2-277.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Harjes U,
    2. Bensaad K,
    3. Harris AL
    . Endothelial cell metabolism and implications for cancer therapy. Br J Cancer. 2012;107:1207–1212. doi: 10.1038/bjc.2012.398.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Dodson M,
    2. Darley-Usmar V,
    3. Zhang J
    . Cellular metabolic and autophagic pathways: traffic control by redox signaling. Free Radic Biol Med. 2013;63:207–221. doi: 10.1016/j.freeradbiomed.2013.05.014.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Bricker DK,
    2. Taylor EB,
    3. Schell JC,
    4. et al
    . A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science. 2012;337:96–100. doi: 10.1126/science.1218099.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Burnstock G
    . Release of vasoactive substances from endothelial cells by shear stress and purinergic mechanosensory transduction. J Anat. 1999;194 (pt 3):335–342.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Peti-Peterdi J,
    2. Kishore BK,
    3. Pluznick JL
    . Regulation of vascular and renal function by metabolite receptors. Annu Rev Physiol. 2016;78:391–414. doi: 10.1146/annurev-physiol-021115-105403.
    OpenUrlCrossRef
  30. 30.↵
    1. da Silva CG,
    2. Specht A,
    3. Wegiel B,
    4. Ferran C,
    5. Kaczmarek E
    . Mechanism of purinergic activation of endothelial nitric oxide synthase in endothelial cells. Circulation. 2009;119:871–879. doi: 10.1161/CIRCULATIONAHA.108.764571.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Bültmann R,
    2. Tuluc F,
    3. Starke K
    . On the suitability of adenosine 3’-phosphate 5’-phosphosulphate as a selective P2Y receptor antagonist in intact tissues. Eur J Pharmacol. 1998;359:95–101.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Sud N,
    2. Kumar S,
    3. Wedgwood S,
    4. Black SM
    . Modulation of PKCdelta signaling alters the shear stress-mediated increases in endothelial nitric oxide synthase transcription: role of STAT3. Am J Physiol Lung Cell Mol Physiol. 2009;296:L519–L526. doi: 10.1152/ajplung.90534.2008.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Sun MK,
    2. Alkon DL
    . Bryostatin-1: pharmacology and therapeutic potential as a CNS drug. CNS Drug Rev. 2006;12:1–8. doi: 10.1111/j.1527-3458.2006.00001.x.
    OpenUrlCrossRefPubMed
  34. 34.↵
    1. Wender PA,
    2. Nakagawa Y,
    3. Near KE,
    4. Staveness D
    . Computer-guided design, synthesis, and protein kinase C affinity of a new salicylate-based class of bryostatin analogs. Org Lett. 2014;16:5136–5139. doi: 10.1021/ol502491f.
    OpenUrl
  35. 35.↵
    1. Lavandero S,
    2. Troncoso R,
    3. Rothermel BA,
    4. Martinet W,
    5. Sadoshima J,
    6. Hill JA
    . Cardiovascular autophagy: concepts, controversies, and perspectives. Autophagy. 2013;9:1455–1466. doi: 10.4161/auto.25969.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Lavandero S,
    2. Chiong M,
    3. Rothermel BA,
    4. Hill JA
    . Autophagy in cardiovascular biology. J Clin Invest. 2015;125:55–64. doi: 10.1172/JCI73943.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. De Meyer GR,
    2. Grootaert MO,
    3. Michiels CF,
    4. Kurdi A,
    5. Schrijvers DM,
    6. Martinet W
    . Autophagy in vascular disease. Circ Res. 2015;116:468–479. doi: 10.1161/CIRCRESAHA.116.303804.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Torisu K,
    2. Singh KK,
    3. Torisu T,
    4. Lovren F,
    5. Liu J,
    6. Pan Y,
    7. Quan A,
    8. Ramadan A,
    9. Al-Omran M,
    10. Pankova N,
    11. Boyd SR,
    12. Verma S,
    13. Finkel T
    . Intact endothelial autophagy is required to maintain vascular lipid homeostasis. Aging Cell. 2016;15:187–191. doi: 10.1111/acel.12423.
    OpenUrl
  39. 39.↵
    1. Sessa WC
    . eNOS at a glance. J Cell Sci. 2004;117(pt 12):2427–2429. doi: 10.1242/jcs.01165.
    OpenUrlFREE Full Text
  40. 40.↵
    1. Shaul PW
    . Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol. 2002;64:749–774. doi: 10.1146/annurev.physiol.64.081501.155952.
    OpenUrlCrossRefPubMed
  41. 41.↵
    1. Fulton D,
    2. Gratton JP,
    3. Sessa WC
    . Post-translational control of endothelial nitric oxide synthase: why isn’t calcium/calmodulin enough? J Pharmacol Exp Ther. 2001;299:818–824.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    1. Dudzinski DM,
    2. Michel T
    . Life history of eNOS: partners and pathways. Cardiovasc Res. 2007;75:247–260. doi: 10.1016/j.cardiores.2007.03.023.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Andrews AM,
    2. Jaron D,
    3. Buerk DG,
    4. Barbee KA
    . Shear stress-induced NO production is dependent on ATP autocrine signaling and capacitative calcium entry. Cell Mol Bioeng. 2014;7:510–520. doi: 10.1007/s12195-014-0351-x.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Kirby PL,
    2. Buerk DG,
    3. Parikh J,
    4. Barbee KA,
    5. Jaron D
    . Mathematical model for shear stress dependent NO and adenine nucleotide production from endothelial cells. Nitric Oxide. 2016;52:1–15. doi: 10.1016/j.niox.2015.10.004.
    OpenUrl
  45. 45.↵
    1. Bodin P,
    2. Burnstock G
    . Evidence that release of adenosine triphosphate from endothelial cells during increased shear stress is vesicular. J Cardiovasc Pharmacol. 2001;38:900–908.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Yegutkin G,
    2. Bodin P,
    3. Burnstock G
    . Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5’-nucleotidase along with endogenous ATP from vascular endothelial cells. Br J Pharmacol. 2000;129:921–926. doi: 10.1038/sj.bjp.0703136.
    OpenUrlCrossRefPubMed
  47. 47.↵
    1. Webb TE,
    2. Feolde E,
    3. Vigne P,
    4. Neary JT,
    5. Runberg A,
    6. Frelin C,
    7. Barnard EA
    . The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase. Br J Pharmacol. 1996;119:1385–1392.
    OpenUrlCrossRefPubMed
  48. 48.↵
    1. Parker PJ,
    2. Murray-Rust J
    . PKC at a glance. J Cell Sci. 2004;117(pt 2):131–132. doi: 10.1242/jcs.00982.
    OpenUrlFREE Full Text
  49. 49.↵
    1. Kazanietz MG
    . Novel “nonkinase” phorbol ester receptors: the C1 domain connection. Mol Pharmacol. 2002;61:759–767.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    1. Sun MK,
    2. Hongpaisan J,
    3. Lim CS,
    4. Alkon DL
    . Bryostatin-1 restores hippocampal synapses and spatial learning and memory in adult fragile x mice. J Pharmacol Exp Ther. 2014;349:393–401. doi: 10.1124/jpet.114.214098.
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    1. Donato AJ,
    2. Morgan RG,
    3. Walker AE,
    4. Lesniewski LA
    . Cellular and molecular biology of aging endothelial cells. J Mol Cell Cardiol. 2015;89(pt B):122–135. doi: 10.1016/j.yjmcc.2015.01.021.
    OpenUrlCrossRefPubMed
  52. 52.↵
    1. de Zeeuw P,
    2. Wong BW,
    3. Carmeliet P
    . Metabolic adaptations in diabetic endothelial cells. Circ J. 2015;79:934–941. doi: 10.1253/circj.CJ-15-0230.
    OpenUrlCrossRefPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Arteriosclerosis, Thrombosis, and Vascular Biology
September 2017, Volume 37, Issue 9
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Sources of Funding
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Endothelial Cell Autophagy Maintains Shear Stress–Induced Nitric Oxide Generation via Glycolysis-Dependent Purinergic Signaling to Endothelial Nitric Oxide Synthase
    Leena P. Bharath, Jae Min Cho, Seul-Ki Park, Ting Ruan, Youyou Li, Robert Mueller, Tyler Bean, Van Reese, Russel S. Richardson, Jinjin Cai, Ashot Sargsyan, Karla Pires, Pon Velayutham Anandh Babu, Sihem Boudina, Timothy E. Graham and J. David Symons
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2017;37:1646-1656, originally published July 6, 2017
    https://doi.org/10.1161/ATVBAHA.117.309510

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Arteriosclerosis, Thrombosis, and Vascular Biology.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Endothelial Cell Autophagy Maintains Shear Stress–Induced Nitric Oxide Generation via Glycolysis-Dependent Purinergic Signaling to Endothelial Nitric Oxide Synthase
    (Your Name) has sent you a message from Arteriosclerosis, Thrombosis, and Vascular Biology
    (Your Name) thought you would like to see the Arteriosclerosis, Thrombosis, and Vascular Biology web site.
  • Share on Social Media
    Endothelial Cell Autophagy Maintains Shear Stress–Induced Nitric Oxide Generation via Glycolysis-Dependent Purinergic Signaling to Endothelial Nitric Oxide Synthase
    Leena P. Bharath, Jae Min Cho, Seul-Ki Park, Ting Ruan, Youyou Li, Robert Mueller, Tyler Bean, Van Reese, Russel S. Richardson, Jinjin Cai, Ashot Sargsyan, Karla Pires, Pon Velayutham Anandh Babu, Sihem Boudina, Timothy E. Graham and J. David Symons
    Arteriosclerosis, Thrombosis, and Vascular Biology. 2017;37:1646-1656, originally published July 6, 2017
    https://doi.org/10.1161/ATVBAHA.117.309510
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Vascular Disease
    • Vascular Disease
  • Basic, Translational, and Clinical Research
    • Vascular Biology
    • Physiology
    • Endothelium/Vascular Type/Nitric Oxide
    • Basic Science Research

Arteriosclerosis, Thrombosis, and Vascular Biology

  • About ATVB
  • AHA CME
  • Meeting Abstracts
  • Permissions
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Contact the Editorial Office:
email: atvb@atvb.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured